iDose versus DURYSTA

Here is a comprehensive list based on the available web results concerning comparisons of iDose versus DURYSTA, their efficacy, and details about Medicare coverage and pricing:

 Comparative Publications:

- Direct Comparison:

  - There is no direct mention of publications comparing iDose versus DURYSTA in the provided search results. However, general discussions about these treatments are noted in contexts like post-cataract surgery care:

    - *Covid-19 & Cataract Surgery – Patients* discusses both DURYSTA and iDose in the context of new SR technologies for postoperative care but does not compare them directly.(https://cataractpatients.com/cataract-cataracts-covid-19-cataract-surgery-patients)

 Efficacy Publications:

- DURYSTA (bimatoprost intracameral implant):

  - Efficacy Overview: DURYSTA has been shown to control intraocular pressure (IOP) month after month in clinical studies. The most common ocular adverse reaction reported was conjunctival hyperemia, with other reactions like eye pain and photophobia also noted.(https://www.durystahcp.com/)

  - Clinical Studies: Efficacy was demonstrated in two multicenter, randomized, parallel-group, controlled studies where DURYSTA was compared to twice-daily topical timolol drops in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).(https://www.durystahcp.com/)

- iDose (travoprost implant):

  - Efficacy Overview: While specific publications directly addressing iDose's efficacy are not detailed in the search results, there's mention of its potential to deliver travoprost for about a year, suggesting long-term efficacy in managing IOP. However, iDose is still in trials according to the information provided.(https://cataractpatients.com/cataract-cataracts-covid-19-cataract-surgery-patients)

 Pricing and Medicare Coverage:

- DURYSTA:

  - Pricing: The cost for DURYSTA 10 mcg intraocular implant is around $2,102 for a supply of one implant. This price is for cash-paying customers and might not reflect insurance-covered costs.(https://www.drugs.com/price-guide/durysta)

  - Medicare Coverage: DURYSTA is covered under Medicare Part B as a medical benefit, not under Part D. Traditional Medicare covers 80% of the cost, potentially leaving patients with out-of-pocket expenses unless covered further by supplemental insurance. Medicare Advantage plans follow similar coverage guidelines but might require prior authorization.(https://crstoday.com/articles/allergan-supplement-0321/billing-reimbursement-for-durysta-bimatoprost-intracameral-implant-in-your-practice-2)

- iDose:

  - Pricing: No specific pricing information for iDose is provided since it is still in the development and trial phase according to the search results. 

  - Medicare Coverage: Given its current status, discussions on Medicare coverage for iDose are speculative. However, if it follows a similar path to DURYSTA, it might be covered under Medicare Part B for procedural benefits.

 Additional Notes:

- The information on iDose is limited due to its ongoing trial status. 

- For both medications, patient assistance programs and copay cards might be available to reduce out-of-pocket costs, but these specifics are not detailed in the provided results.

Keep in mind that this data is based on the provided search results which might not be exhaustive or up-to-date as of January 16, 2025. For the most current details on pricing, coverage, or new publications, additional research or direct inquiries to the manufacturers or healthcare providers would be necessary.